Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Asia-Pacific Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drugs and OTC Drugs)
- Report Code : TIPRE00014198
- Pages : 127
The APAC dry eye products market is expected to grow from US$ 1,298.49 million in 2021 to US$ 1,900.70 million by 2028. It is estimated to grow at a CAGR of 5.6% from 2021 to 2028.
Ongoing Research and Growing Pipeline for Dry Eye Products
The dry eye condition is expected to be seen in the majority of the population across the region in the coming years. Many research studies have proven dry eye as a lifestyle disease. Improvements or changes in daily habits such as sleep, diet, and exercise are included in the treatment of dry eyes. Additionally, the stressful life among people across the region is likely to increase the incidence of dry eyes, thereby propelling the demand for dry eye products in the coming years. Technological advancements have resulted in an increase in product development. Various companies are entering the market, which is contributing greatly to enhancing market growth. Various companies have designed innovative formulae to offer better eye drops for dry eye conditions. The cycle of product development is continuous and is likely to act as a vital growth factor during the forecast period. Some companies are focusing on innovating other forms of products that can treat dry eye conditions. Several innovations are likely to act as trending factors and are expected to contribute significantly to the market growth in the coming years across the region.
Market Overview
The APAC dry eye products market includes the consolidated markets for China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan held the largest share of the APAC dry eye products market in 2021. In Japan, dry eye is the leading diagnosed eye condition that shows prevalent symptoms among high school students. The incidence among students is higher due to long hours in front of computers and mobiles. The incidence is seen widely among females wearing contact lenses. Therefore, the Japanese Dry Eye Society has introduced various diagnostic criteria for dry eye symptoms. In addition, technological development has allowed the Japanese to develop the P2Y2 antagonist Diquas and the mucin secretagogue Mucosta. The development of these products was based on the tear instability concept. The process of development was conducted for more than five years. At present, the products are widely prescribed. However, these eye drops have been commercially available since 2010 in Japan. Santen Pharmaceutical Co., Ltd has made its product Diquas, an ophthalmic solution, 3%, available since 2010. Similarly, in 2012, Otsuka Pharmaceutical Co., Ltd made its Mucosta ophthalmic suspension UD2% commercially available. Thus, the product development of eye drops for dry eye condition is likely to influence market growth.
APAC Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)
APAC Dry Eye Products Market Segmentation
The APAC dry eye products market is segmented based on product, type, and country.
Based on product, the APAC dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.
Based on type, the APAC dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.
Based on country, the APAC dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan dominated the market in 2021.
AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the APAC dry eye products market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Dry Eye Products Market – By Product
1.3.2 APAC Dry Eye Products Market – By Type
1.3.3 APAC Dry Eye Products Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Dry Eye Products Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Dry Eye Products Market – Key Market Dynamics
5.1 Market Driver
5.1.1 Rising Incidences of Dry Eye
5.1.2 Growing Older Population
5.2 Market Restraints
5.2.1 Side Effects Caused Due to Eye Drops
5.3 Market Opportunities
5.3.1 Stem Cell Therapy
5.4 Future Trends
5.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
5.5 Impact Analysis of Drivers and Restraints
6. Dry Eye Products Market – APAC Analysis
6.1 APAC Dry Eye Products Market Revenue Forecast and Analysis
7. APAC Dry Eye Products Market Analysis – By Product
7.1 Overview
7.2 APAC Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
7.3 Artificial Tears
7.3.1 Overview
7.3.2 Artificial Tears: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Over-The-Counter (OTC) Artificial Tears
7.3.3.1 Overview
7.3.3.2 OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Prescription Artificial Tears
7.3.4.1 Overview
7.3.4.2 Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.4 Antibiotics Drops
7.4.1 Overview
7.4.2 Antibiotic Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Hormone Drops
7.5.1 Overview
7.5.2 Hormone Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Dry Eye Products Market Analysis – By Type
8.1 Overview
8.2 APAC Dry Eye Products Market, by Type, 2021 and 2028 (%)
8.3 OTC Drugs
8.3.1 Overview
8.3.2 OTC Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Prescription Drugs
8.4.1 Overview
8.4.2 Prescription Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9. APAC Dry Eye Products Market – Country Analysis
9.1 Overview
9.1.2 APAC: Dry Eye Products Market, by Country, 2021 & 2028 (%)
9.1.3 China: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1 Overview
9.1.3.2 China: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3 China: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.1 China: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.3.4 China: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.4 Japan: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1 Overview
9.1.4.2 Japan: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3 Japan: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 Japan: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.4.4 Japan: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.5 India: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1 Overview
9.1.5.2 India: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3 India: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 India: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.5.4 India: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.6 South Korea: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.6.1 Overview
9.1.6.2 South Korea: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.6.3 South Korea: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.6.3.1 South Korea: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.6.4 South Korea: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.7 Australia: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.7.1 Overview
9.1.7.2 Australia: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.7.3 Australia: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.7.3.1 Australia: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.7.4 Australia: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.8 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.8.1 Overview
9.1.8.2 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.8.3 Rest of APAC: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.8.3.1 Rest of APAC: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.8.4 Rest of APAC: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10. Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Santen Pharmaceutical Co., Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Johnson and Johnson Services, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 OASIS Medical
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 URSAPHARM Arzneimittel GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ROHTO Pharmaceutical Co, Ltd.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 OCuSOFT Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bausch Health Companies Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 AbbVie Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Prestige Consumer Healthcare Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms
LIST OF TABLES
Table 1. APAC Dry Eye Products Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 4. China: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. India: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 10. India: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of APAC: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of APAC Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of APAC: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Dry Eye Products Market Segmentation
Figure 2. APAC Dry Eye Products Market – By Country
Figure 3. APAC Dry Eye Products Market Overview
Figure 4. APAC Dry Eye Products Market, By Product
Figure 5. APAC Dry Eye Products Market, By Country
Figure 7. APAC PEST Analysis
Figure 8. Expert Opinion
Figure 9. APAC Dry Eye Products Market Impact Analysis of Drivers and Restraint
Figure 10. APAC Dry Eye Products Market – Revenue Forecast And Analysis
Figure 11. APAC Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
Figure 12. APAC Artificial Tears: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Antibiotic Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Hormone Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Others: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Dry Eye Products Market, by Type, 2021 and 2028 (%)
Figure 19. APAC OTC Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Prescription Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC: Dry Eye Products Market, by Key Country – Revenue (2021) (US$ Million)
Figure 22. APAC: Dry Eye Products Market, by Country, 2021 & 2028 (%)
Figure 23. China: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Japan: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. India: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Korea: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Australia: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC dry eye products market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the APAC dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
● AbbVie Inc
● Bausch Health Companies Inc.
● Johnson and Johnson Services, Inc.
● Novartis AG
● OASIS Medical
● OCuSOFT Inc.
● Prestige Consumer Healthcare Inc.
● ROHTO Pharmaceutical Co, Ltd.
● Santen Pharmaceutical Co., Ltd.
● URSAPHARM Arzneimittel GmbH
At 5.6% CAGR, the APAC Eye Products Market is speculated to be worth US$ 1,900.70 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the APAC eye products market was valued at US$ 1,298.49 million in 2021 and is expected to reach US$ 1,900.70 million by 2028, registering a CAGR of 5.6% from 2021 to 2028. Advancement such as stem cell therapy and ongoing research and growing pipeline for dry eye products are the critical factors attributed to the market expansion.
The technologies are emerging based on stem cell therapy that can help in treating a dry eye condition. The aim is to prevent disease development, regeneration, and maintaining corneal transparency. Whereas most of the recent advances do not respond to conventional methods. Therefore, researchers prefer autologous or allogeneic serum drops, platelet-derived plasma products, and umbilical cord blood serum to study them as a treatment method. Additionally, the researchers are focusing on using cytokines and different cell sources such as mesenchymal stem cells more preferably to cure dry eye conditions. During the studies, it was found that mesenchymal cells assist in improving tear volume, tear-film stability, epithelial recovery, and the number of goblet cells. The cells help in decreasing the number of meibomian gland injuries in the conjunctiva, which is expected to be the most promising advancement for the dry eye condition treatment. The other stem cell therapy-based treatment is by using lubricin. Lubricin is a protein present in the tear film that allows lubrication in between eye surface and eyelid. The researchers are aiming to introduce proper treatment that can cure dry eye conditions completely. Thus, advancements in the healthcare industry that has allowed integration of biotechnology and pharmaceutical are likely to propel the market growth during the forecast period.
On the contrary, side effects caused due to eye drops hurdles the growth of APAC eye products market.
Based on product, the APAC dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held 48.8% market share in 2021, amassing US$ 633.02 million. It is projected to garner US$ 907.97 million by 2028 to expand at 5.3% CAGR during 2021–2028. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.
Based on type, the APAC dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held 55.1% market share in 2021, amassing US$ 715.28 million. It is projected to garner US$ 1,019.52 million by 2028 to expand at 5.2% CAGR during 2021–2028.
Based on country, the APAC dry eye products market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that Japan captured 26.4% market share in 2021. It was assessed at US$ 343.21 million in 2021 and is likely to hit US$ 520.55 million by 2028, exhibiting a CAGR of 6.1% during the forecast period.
Key players dominating the APAC dry eye products market are AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH among others.
In Nov 2017, Santen Pharmaceutical Co., Ltd received its import drug license for its product Diquas Ophthalmic Solution (generic name: diquafosol sodium), for the dry eye treatment of patients in China. This approval has provided the company high potential for business growth in the region and country. In Jan 2020, Santen Pharmaceutical Co., Ltd as a part of its business expansion in China has decided to construct its second plant for its Chinese subsidiary “Santen Pharmaceutical (China) Co., Ltd.” to support the growing demand for products in China.
Related Reports
- $3,000.00 – $5,000.00
